SynchroMed(TM) II

More
Innovation
No More
Certifications

Please watch the Animation


NO MORE CERTIFICATES WITH SYNCHROMED™ II IMPLANTS

That is because Medtronic invested and successfully navigated through the consent decree* deliverables to ensure patients continue to receive the therapy. Medtronic delivered on all FDA expectations in regards to a quality work plan and product enhancements, which enabled us to exit the certification process.

NO MORE CERTIFICATES WITH SYNCHROMED™ II IMPLANTS

* Consent decree is a formal agreement with the FDA to address its expectations in regards to: (a) SynchroMed™ II and; (b) overall neuromodulation quality system. It gives the FDA greater oversight of our existing quality improvement efforts and provides a path forward with steps and timelines (three pillars, quality work plan, pump remediation plan and distribution controls/notification of associated persons).


Tick Icon

BETTER PRODUCT
Using Medtronic’s scale and real-life data with a registry of almost 7,500 patients, and returned product analysis, we have identified three main causes for the majority of motor stalls. This is why we have recently improved SynchroMed™ II with four durable design enhancements that aim to improve reliability and bring motor stalls 
to a minimum.

 

Addressing causes of motor stalls infographic

1 Based on all pumps returned and analyzed for motorstalls
2 Medtronic data on file. The implementation of these three design changes
  does not imply an equivalent percent reduction in motor stall


Handshake icon

BETTER QUALITY PROCESSES
Medtronic has worked with best-in-class external experts in quality, to develop robust business processes to ensure optimum quality. This aims to consistently meet our customers and patients’ requirements and enhance their satisfaction. Our new quality processes have successfully passed third party and FDA audits in 2017.


Win icon

BRIGHTER FUTURE
We are fully focused on investing into innovations that will positively impact your practice and improve your patients’ lives. Over the upcoming months you will be exposed to a range of new product innovations and level 1 clinical evidence, so stay tuned!


We aim to impact you positively

Image of Patient

INCREASED PATIENT SAFETY:

Durable Design enhancements aim to reduce motor stalls, and therefore reduce the risk of over/ underdose and revision surgeries.

Image of PHYSICIAN

INCREASED PHYSICIAN CONFIDENCE:

Through less revision and replacement surgeries, with durable design enhancements and improved quality systems that aim to reduce motor stalls.

Image of Payer

LESS PAYER COSTS:

Through less revision surgeries with durable design enhancements.


WANT TO KNOW MORE?

* Indicates a required field.

I would like to be contacted by a Medtronic Representative
* By checking this box and providing information, I understand and agree that my personal information is being collected by Medtronic and entered into a database for the purpose of communicating offers related to Medtronic products, services and technological advancements. The information I provide will be used and protected in accordance with the Medtronic Privacy Statement.